Invention Grant
- Patent Title: Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorder
-
Application No.: US18221516Application Date: 2023-07-13
-
Publication No.: US12011454B2Publication Date: 2024-06-18
- Inventor: Guillaume Bermond , Laurent Garçon , Matthias Canault , Cecile Cros
- Applicant: Nuvamid SA
- Applicant Address: CH Epalinges
- Assignee: NUVAMID SA
- Current Assignee: NUVAMID SA
- Current Assignee Address: CH Epalinges
- Agency: Harness Dickey & Pierce PLC
- Priority: EP 215833 2020.12.18
- Main IPC: A61K31/706
- IPC: A61K31/706 ; A61K31/198 ; A61P7/06
Abstract:
The present invention relates to nicotinamide mononucleotide derivatives of Formula (I)
for use in the treatment and/or prevention of a blood disorder, especially sickle cell disease. The present invention further relates to pharmaceutical compositions comprising compounds of Formula (I) for use in the treatment and/or prevention of a red blood cell disorder, especially sickle cell disease.
for use in the treatment and/or prevention of a blood disorder, especially sickle cell disease. The present invention further relates to pharmaceutical compositions comprising compounds of Formula (I) for use in the treatment and/or prevention of a red blood cell disorder, especially sickle cell disease.
Public/Granted literature
Information query
